Capítulo 5. 5. Patología neuroendocrina. Hipopituitarismo


1. Heimer L; The Human brain and Spinal Cord. Springer, New Tork, 1983
2. Swanson LW, Kuypers HGJM: The paraventricular nucleus of the hypothalamus. J Comp. Neurol 1980. 194; 555.
3. Percy AK, Elveback LR, Okazaki H, Kurland LT. Neoplasms of the central nervous system: epidemiologic considerations. Neurology 1972; 22, 40-8
4. Laws ER Jr. Pituitary surgery. Endocrinology and Metabolism Clinics of North America 1987; 16: 647-65.
5. Arafah BM, Harrington JF, Madhoum ZT, Selman WR. Improvement of pituitary function after surgical decompression for pituitary tumour apoplejy. J Clin Endocrinol Metab 1990; 71: 323-8.
6. Rolih C, Ober KP. Pituitary apoplexy. Endocrinology and Metabolism Clinics of North América 1993 June 22 (2)291-302.
7. Constine LS, Woolf PD, Cann D et al. Hypothalamic-pituitary dysfunction after radiation of brain tumors. N. Eng. J.Med. 1993; 328: 87-94
8. Glick RP, Tiesi JA. Subacute pituitary apoplejy. Clinical and magnetic resonance imaging characteristics. Neurosurgery 1990; 27.214,
9. Fitz-Patrick D, Tolis G, Mc Garry EE, et al. Pituitary apoplexyThe importance of skull rontgenograms and computerized tomography in diagnosis. JAMA, 1980; 244: 59-61 
10. Onesti ST, WisniewskiT, Post KD. Clinical versussubclinical pituitary apoplexy: Presentation, surgical management and outcome in 21 patients.
Neurosurgery 1990; 26: 980-986
11. Movsas B; Movsas TZ; et al. Long-term visual changes following pituitary irradiation: Int J Radiat Oncol Biol Phys. 1995 Oct 15. 33(3). 599-605. 
12. Zucchini S; Ambrosetto P; Carla G; et al Primary empty sella: differences and similarities between children and adults.Acta Paediatr. 1995 Dec. 84(12). 1382-5.
13. Hackl JM, Gottardis M, Wieser CH, Rumpl E, Stadler Ch, Schwarz S, Monkayo R. Endocrine abnormalities in severe traumatic brain injury a cue to prognosis in severe craniocerebral trauma ? Intensive Care Medicine 1991; 17: 25-29.
14. Vance al Hypopituitarism. N. Eng. J. Med. 1994; 330(23): 1651-1662. 
15. Reasner II CA, Mueller GL. Hypothalamic and Pituitary Disease in Critical Care Third edition. Civetta JM, taylor RW, Kirby -Lippincott-Raven Publishers 1997, 211-2119 
16. Longscope C. Crisis Hipoadrenal in Intensive Care Medicine Rippe JM, Irwin RS, Alport J.S, Fink MP. Second edition 1991; 983-8.
17. Emerson C.H. Coma Myxedema inIntensive Care Medicine. Rippe JM, Irwin RS, Alport JS, Fink MP. Second edition 1991; 980-2.
18. Cuneo RC. Current strategies for hormone replacement therapy for the hypopituitary patient. Med J Aust. 1995 Nov 20. 163(10). 539-41. 
19. Arafah BM; Nekl KE; Gold RS; Selman WR. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.J
Clin Endocrinol Metab. 1995 Dec. 80(12). 3507-12.
20. Ober KP.Diabetes insipidus Crit Care Clinics 1991 (7): 109-125. 
21. Robertson GL. Diabetes insipidus.Endocrinol Metab Clin North Am. 1995 Sep. 24(3). 549-72.
22. Robinson AG, DDAVP in the treatment of central Diabets insipidus. N Eng J Med. 1976,294: 507-511 
23. Buonocore C, Robinson Alain The diagnosis and management of Diabetes Insipidus during medical emergencies. Endocrinology and Metabolism Clinics of North America 1993 June 22 (2) 411-423.
24. Chernow B, Wiley SC., Zaloga GP. Terapia Intensiva en Endocrinología en Tratado de Medicina Crítica y Terapia Intensiva. Shoemaker WC, Ayres S, Grenvick A, Thompson WL. Segunda edición Editorial panamericana; 808-38.
25. Schlaghecke R, Kornely E, Santen RT, Riidderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N. Eng. J. Med. 1992; 326: 226-30.